NCT05912972Recruiting
Development and Management of Registry in Patients With Gynecologic Cancer in Korea
Source: ClinicalTrials.gov · Last updated 22 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 13500 (estimated)
- First submitted
- 12 Jun 2023
- Start date
- 21 Oct 2022
- Primary completion date
- 21 Oct 2027
- Lead sponsor
- Asan Medical Center
- Diseases
- Endometrial cancer, Cervical cancer, Ovarian cancer
- NCT number
- NCT05912972
What you commit to
- Study type: Observational
- Planned participants: 13500
- From 21 Oct 2022 to the primary completion date, 21 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Who the study is looking for
- Female patients 18 years or older
- Written informed consent (prospective cohort)
- Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.